muj-logologoIITBombay-Logo

Call for Papers

Call for Papers - Submit your original research and be part of the global dialogue on International Conference on Biotechnology in Health Science and Therapeutics

Submission Guidelines

All submitted abstracts will undergo a review process by a panel of experts. The participants are requested to submit the structured abstract in prescribed format at the conference website.

Submission Requirements

  • • Original, unpublished research
  • • High-quality academic content
  • • Follow conference format guidelines
  • • Peer-review process

Presentation Formats

  • • Oral presentations
  • • Poster presentations
  • • Panel discussions
  • • Interactive sessions

Submission Timeline

1

Abstract Submission

31st October 2025

2

Acceptance Notification:

15th November 2025

3

Early Bird Registration

30th November 2025

4

Full Paper Submission

20th December 2025

5

Last date of Registration:

20th December 2025

Conference Tracks

Innovations in Infectious Disease Management

  • Rapid diagnostics and point-of-care testing
  • Vaccine development and production
  • Antimicrobial drug discovery
  • Genetic engineering for disease resistance

Biotechnology in Cancer Therapeutics & Diagnostics

  • Gene and cell therapies (CAR-T, gene editing)
  • Liquid biopsies and molecular diagnostics
  • Immunotherapy and targeted therapies
  • Cancer nanomedicine

Biotechnology for Neurological & Cardiovascular Health

  • Gene and cell therapies for neurodegenerative disorders
  • Biomarkers for early disease detection
  • Regenerative approaches for heart tissue
  • Novel drug delivery systems for the central nervous system

Computational Biology & Omics for Precision Medicine

  • Genomics and Transcriptomics in Disease
  • Bioinformatics and Data Integration
  • Computational Modeling and Systems Biology
  • Artificial Intelligence and Machine Learning in Biology

Regenerative Medicine & Tissue Engineering

  • Stem cell research and therapy
  • 3D bioprinting and biofabrication
  • Biomaterials and scaffolds
  • Clinical trials in regenerative medicine

Environmental Biotechnology, Human Health, and IPR

  • Ecotoxicology, Emerging pollutants and human health risks
  • Bioremediation and biotechnological approaches for waste management
  • Climate change mitigation and health
  • Intellectual property rights (IPR) with environmental and health-conscious green manufacturing